Committee for the Safety of Medicinal Products for Human Use

Advisory body of the AEMPS in Spain that assessed the benefit-risk balance of menopausal hormone therapy in January 2004, recommending restrictions on its indications.

Institutional endorsement by Clínica Evolution

This entry is for information. Your case requires an individual medical assessment.